AVITA Medical (ASX:AVH) Other Net Income (Loss) : A$0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is AVITA Medical Other Net Income (Loss)?

AVITA Medical's Other Net Income (Loss) for the three months ended in Mar. 2025 was A$0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was A$0.0 Mil.

AVITA Medical's quarterly Other Net Income (Loss) stayed the same from Sep. 2024 (A$0.0 Mil) to Dec. 2024 (A$0.0 Mil) but then increased from Dec. 2024 (A$0.0 Mil) to Mar. 2025 (A$0.0 Mil).

AVITA Medical's annual Other Net Income (Loss) increased from Dec. 2022 (A$-0.0 Mil) to Dec. 2023 (A$0.0 Mil) but then declined from Dec. 2023 (A$0.0 Mil) to Dec. 2024 (A$-0.0 Mil).

AVITA Medical Other Net Income (Loss) Historical Data

The historical data trend for AVITA Medical's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Other Net Income (Loss) Chart

AVITA Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

AVITA Medical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

AVITA Medical Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.0 Mil.

AVITA Medical Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (ASX:AVH) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

RCEL:USA AVHHL:USA 51KB:Germany

Address

28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

AVITA Medical Headlines

No Headlines